Title: Patient Compliance and Awareness with Thyroid Replacement Therapy
Authors: Dr Amer Ahmed Balla, Hanan Ahmed Alanazi, Maha Khalaf Alenazy, Sara Mohammed Otaywi
DOI: https://dx.doi.org/10.18535/jmscr/v4i12.126
Abstract
Thyroid diseases notably hypoactive gland is challenging in northern borders region. Despite lack of clear statistical data, the disorder is one of the commonly seen health problems in the outpatient department.
Hypothyroidism is mostly diagnosed with ease as the clinical features are clear and the diagnostic tools are available and accurate.
This descriptive study is proposed to highlight patient awareness and compliance with thyroid hormone replacement therapy in northern borders region.
References
1. Zulewski H, Muller B, Exer P, et al. Estimation of tissue hypothyroidism by a new clinical score: evaluation of patients with various grades of hypothyroidism and controls. J Clin Endocrinol Metab. 1997; 2:771- 776.
2. Garber JR, Cobin RH, Gharib H, et al. American Association of Clinical Endocr-inologists and American Thyroid Associ-ation Taskforce on Hypothyroidism. Clinical practice guidelines for hypothyro-idism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Thyroid. 2012;22: 1200-1235.
3. Biondi B, Wartofsky L. Treatment with thyroid hormone. Endocr Rev. 2014;35:433-512.
4. Gereben B, Zavacki AM, Ribich S, et al. Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling. Endocr Rev. 2008; 29:898-938.
5. Biondi B, Wartofsky L. Combination treatment with T4 and T3: toward personalized replacement therapy in hypothyroidism? J ClinEndocrinolMetab. 2012;97:2256-2271.
6. Wiersinga WM, Duntas L, Fadeyev V, et al. 2012 ETA guidelines: the use of L-T4 + L-T3 in the treatment of hypothyro-idism. Eur Thyroid J. 2012;1:55-71..
7. Bach-Huynh TG, Nayak B, Loh J, et al. Timing of levothyroxine administration affects serum thyrotropin concentration. J Clin Endocrinol Metab. 2009;94:3905-3912.
8. Hennessey JV. Levothyroxine a new drug? Since when? How could that be? Thyroid. 2003;13:279-282
9. Santini F, Pinchera A, Marsili A, et al. Lean body mass is a major determinant of levothyroxine dosage in the treatment of thyroid diseases. J ClinEndocrinolMetab. 2005;90:124-127.
10. Centanni M, Gargano L, Canettieri G, et al. Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis. N Engl J Med. 2006;354: 1787-1795.
11. Carr D, McLeod DT, Parry G, Thornes HM. Fine adjustment of thyroxine replacement dosage: comparison of the thyrotrophin releasing hormone test using a sensitive thyrotrophin assay with measurement of free thyroid hormones and clinical assessment. ClinEndocrinol (Oxf). 1988;28:325-333.
12. Slawik M, Klawitter B, Meiser E, et al. Thyroid hormone replacement for central hypothyroidism: a randomized controlled trial comparing two doses of thyroxine (T4) with a combination of T4 and triiodothyronine. J ClinEndocrinolMetab. 2007;92:4115-4122
13. Van Dop C, Conte FA, Koch TK, et al. Pseudotumorcerebri associated with initiation of levothyroxine therapy for juvenile hypothyroidism. N Engl J Med. 1983;308:1076-1080.
14. Leung AM, Braverman LE. Iodine-induced thyroid dysfunction. Curr Opin Endocrinol Diabetes Obes. 2012;19:414-419.
15. Bogazzi F, Tomisti L, Bartalena L, et al. Amiodarone and the thyroid: a 2012 update. J Endocrinol Invest. 2012;35:340-348.
16. Arafah BM. Decreased levothyroxine requirement in women with hypothyroid-ism during androgen therapy for breast cancer. Ann Intern Med. 1994;121:247-251.
17. Mandel SJ, Larsen PR, Seely EW, Brent GA. Increased need for thyroxine during pregnancy in women with primary hypothyroidism. N Engl J Med. 1990;323:91-96.
18. Stagnaro-Green A, Abalovich M, Alexander E, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid. 2011;21: 1081-1125.
19. De Groot L, Abalovich M, Alexander EK, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012;97:2543- 2565.
20. Alexander EK, Marqusee E, Lawrence J, et al. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med. 2004;351:241-249.
21. Loh JA, Wartofsky L, Jonklaas J, Burman KD. The magnitude of increased levothyroxine requirements in hypothyroid pregnant women depends upon the etiology of the hypothyroidism. Thyroid. 2009;19:269-275.
22. Stagnaro-Green A, Pearce E. Thyroid disorders in pregnancy. Nat Rev Endocrinol. 2012;8:650-658.
23. Negro R, Mestman JH. Thyroid disease in pregnancy. Best Pract Res Clin Endocrinol Metab. 2011;25:927-943.
24. Barbesino G. Drugs affecting thyroid function. Thyroid. 2010;20: 763-770.
25. Marcocci C, Golia F, Bruno-Bossio G, et al. Carefully monitored levothyroxine suppressive therapy is not associated with bone loss in premenopausal women. J ClinEndocrinolMetab. 1994;78:818-823.
26. Gogakos AI, Duncan Bassett JH, Williams GR. Thyroid and bone. Arch Biochem Biophys. 2010;503:129-136..
27. Franklyn JA. The thyroid—too much and too little across the ages. The consequ-ences of subclinical thyroid dysfunction. ClinEndocrinol (Oxf). 2013;78:1-8.
28. Danzi S, Klein I. Thyroid hormone and the cardiovascular system. Med Clin North Am. 2012;96:257-268.
29. Benvenga S. When thyroid hormone replacement is ineffective? Curr Opin Endocrinol Diabetes Obes. 2013;20:467-477
30. Benvenga S. When thyroid hormone replacement is ineffective? Curr Opin Endocrinol Diabetes Obes. 2013;20:467-477.
